Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD.

Zsófia Lázár Alpár HorváthSzilvia Kiss-DalaZsolt Abonyi-Tóth Balazs CsomaKatalin KontzLilla Tamási Veronika Muller

Published in: European clinical respiratory journal (2024)

Fewer patients show BDR+ according to the 2021 criteria in comparison with the 2005 recommendations, and protocols for BDR testing may consider the assessment of response to both SABA and SAMA after 30 minutes.

Keyphrases

chronic obstructive pulmonary disease
end stage renal disease
lung function
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
air pollution
combination therapy